TruScreen Group Limited

medical devices

About

TruScreen Group Limited is a New Zealand-based public medical device company that specializes in developing and commercializing an AI-enabled diagnostic device for cervical cancer screening. The device detects precancerous and cancerous changes in cervical tissue in real-time by using a combination of optical and electrical measurements. This technology aims to enhance early detection and improve patient outcomes by providing immediate results, which can lead to faster clinical decisions. The company primarily serves healthcare providers, including hospitals and clinics, that require effective cervical cancer screening tools. TruScreen's focus on research and development supports its commitment to advancing its technology and maintaining a competitive edge in the medical device sector. With a small team and a market capitalization of approximately NZD 13.45 to 16.58 million, TruScreen is dedicated to addressing the critical needs in women's health diagnostics.

Technologies

Outlook Microsoft Office 365 Nginx Google Tag Manager YouTube Shutterstock WordPress.org Typekit Mobile Friendly Gravity Forms reCAPTCHA Remote

Keywords

biotechnology medical devices cervical cancer screening medical technology womens health medical equipment manufacturing women's health early detection ai-enabled cervical cancer screening cervical tissue differentiation high sensitivity and specificity cost-effective screening optical-electrical technology medical equipment and supplies manufacturing healthcare infrastructure clinical validation studies clinical validation objective results electrical impedance spectroscopy real-time detection diagnostics global health impact healthcare technology optical technology low-resource settings low and middle-income countries healthcare accessibility in lmics cervical tissue analysis clinical studies b2b

Location

100 Parnell Rd, Auckland, Auckland, New Zealand, 1052

Related Companies

Companies in the same industry